Case Conference April, 4th 2012
05-Apr-2012, Divisi Ginekologi Onkologi RSCMCASE CONFERENCE
1 OUTPATIENT
Mrs. L, 57 yo
Residive Ovarian Carcinoma Stage IIIc Post suboptimal debulking + Chemotherapy CP 6 series
3434281
HISTORY
October 4th, 2010
• Referred by RSUD Gunung Jati for chemotherapy with Endometrioid ovarian ca IIIC (Performed HTSOB + Omentectomy partial 18/9/2010 in RSUD Gunung Jati, Cirebon)
• PA-RSUD Gn. Jati (20/09/10):
1. Endometriosis interna
2.Endometrioid ovarian carcinoma desktra
3.Metastasis endometrioid carcinoma on peritoneum
• à Ovarian cancer st. IIIC post sub optimal debulking ?
• Ca -125 : 163.8 (Pre Op)
• Ca-125: 101.8 (post op)
Previous history: DM(-), HT (-), cor/pulmo disease (-),history of tumor/cancer(-)
Previous history in family: Appendictomy in 1989
Menstruation history:
Regular menstruation, 28-30 day, long of menstruation 6 day, dismenorrhea (-), change pad 2-3x
Marital history:
She was married when she was 24th years old. First marriage for both patient.
Obstetrical history : P2:
1. 30 yo, spontaneuos
2. 26 yo, spontaneuos
Family Planning history : IUD
Social history: Patients : PNS
Husband : retireman
PHYSICAL EXAMINATION on admission
General status, Compos mentis
Height : 147 cm Bw: 55 kg
BP 120/80 mmHg Pulse 84x/min RR 18x/min T 360 C
Conjunctiva : not anemic
Heart/lung : wnl
Abdomen : scar (+)
Extremities : edema -/-
Lymph node :no enlargement in supraclavicular, inguinal lymph node
Gynecological status
• Inspection : wnl
• Inspeculo : smooth vaginal stump, vaginal wall smooth, fluor (-)
• Gyn RVT : intact vaginal wall, uterus not palpable, adnexal mass not palpable
Oncology USG : (October, 4th 2010)
Minimal ascites at right pelvic
No metastasis at liver , lien & renal
Enlargement lymph node left iliac
Post op ca 125 : 101.8 (post op)
Slide review (October, 6th 2010)
Corresponds to previous PA : Adenoca type: endometrioid ovary, moderate diffrentiated.
Metastasis adenoca type endometrioid at omentum
Discussion with Consultant :
è Performed Chemotherapy with : Carboplatin 600 mg + Paxus 270 mg, 6 series
Adjuvant Chemotherapy:
1.CP 1 :15/10/2010
2.CP 2:18/11/2010
3.CP 3: 9/12/2010
4.CP 4: 29/12/2010
5.CP 5: 25/1/2011 à 31/1/2011 : 5.47 u/ml
6.CP 6: 16/2/2011
USG (March,16th 2011) : No abnormal mass & metastase nodul in pelvic cavity &
abdomen
Ca-125 (15/3/2011) : 15.1 u/ml
Discuss with Consultant (16/3/2011)
Will be controlled for 3 months (USG & Ca-125)
Follow Up ( Ca-125)
14/6/2011: 12.2 u/ml
12/9/2011: 11.98 u/ml
14/12/2011: 28.7 u/ml
USG (October, 4th 2010): Minimal ascites at right pelvic, No metastasis at liver,
lien & renal. Enlargement lymph node left iliac
USG (June, 15th 2011) : No abnormal mass in pelvic & abdominal cavity.
USG (Sept, 15th 2011) : No abnormal metastatic mass in pelvic & abdominal
Cavity
USG (Dec, 16th 2011) : No abnormal metastatic mass in pelvic & abdominal
Cavity
17/3/2012: 98.9 u/ml
Oncology USG (March, 20th 2012)
Lymphadenophaty in para aorta and right inguinal
Mass in pelvic cavity susp recurrent
CT Scan (March, 28th 2012) : There was lobulated mass in lower abdominal cavity untill pelvic cavity with size 16.1 x 9.6 x 9.0 cm à Ovarian tumor (malignant). The mass at right paracardial, enlargement paraaortic lymph node, multiple nodul at segmen II,IVA & VII
ASSESMENT
Residive Ovarian Carcinoma III C
History chemotherapy (Carbo-Paxus 6 series)
à 13 month ago
à Platinum sensitive
April, 3rd 2012
Discussion with Prof. Dr.dr. Andrijono,SpOG(K):
è Will be discuss in CC
PLAN
Residive mass à Consider to give chemotherapy (Platinum sensitive)
Laparoscopy exploration
Berita Lainnya
13-Mar-2013,Divisi Ginekologi Onkologi RSCMCase Conference March 13th 2013

Case Conference March 13th 2013

Case Conference March 6th 2013

Case Conference March 6th 2013

Case Conference February 20th 2013

Case Conference February 113th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

Case Conference February 6th 2013

